Female Sexual Dysfunction (FSD)

King R, Belsky J, Mah K et al (2011) Are there different types of female orgasm? Arch Sex Behav 40:865–875PubMed

Kingsberg SA, Simon JA, Goldstein I (2008) The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 5(Suppl 4):182–193PubMed

Kingsberg SA, Tkachenko N, Lucas J et al (2013a) Characterization of orgasmic difficulties by women: focus group evaluation. J Sex Med 10(9):2242–2250. doi:10.​1111/​jsm.​12224 PubMed

Kingsberg SA, Wysocki S, Magnus L et al (2013b) Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med 10(7):1790–1799PubMed

Kovalevsky G (2005) Female sexual dysfunction and use of hormone therapy in postmenopausal women. Semin Reprod Med 23:180–187PubMed

Krychman ML (2011) Vaginal estrogens for the treatment of dyspareunia. J Sex Med 8:666–674PubMed

Laan E, Everaerd W (1995) Determinants of female sexual arousal: psychophysiological theory and data. Annu Rev Sex Res 6:32–76

Laan E, Everaerd W (1998) Physiological measures of vaginal vasocongestion. Int J Impot Res 10(Suppl 2):S107–S110PubMed

Laan E, Rellini AH, Barnes T (2013) Standard operating procedures for female orgasmic disorder: consensus of the International Society for Sexual Medicine. J Sex Med 10:74–82PubMed

Labrie F, Archer D, Bouchard C et al (2009) Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 16:923–931PubMed

Labrie F, Archer D, Bouchard C et al (2010) High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Gynecol Endocrinol 26:524–532PubMed

Lahaie MA, Boyer SC, Amsel R et al (2010) Vaginismus: a review of the literature on the classification/diagnosis, etiology and treatment. Womens Health (Lond Engl) 6:705–719

Lamont JA (1978) Vaginismus. Am J Obstet Gynecol 131:633–636PubMed

Laumann EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States. Prevalence and predictors. JAMA 281:537–544PubMed

Laumann EO, Nicolosi A, Glasser DB et al (2005) Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 17:39–57PubMed

Leddy LS, Yang CC, Stuckey BG et al (2012) Influence of sildenafil on genital engorgement in women with female sexual arousal disorder. J Sex Med 9:2693–2697PubMed

Leiblum SR, Koochaki PE, Rodenberg CA et al (2006) Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause 13:46–56PubMed

Leonard LM, Follette VM (2002) Sexual functioning in women reporting a history of child sexual abuse: review of the empirical literature and clinical implications. Annu Rev Sex Res 13:346–388PubMed

Levine SB et al (2008) Phase 2B bremelanotide study in pre- and postmenopausal women with FSAD. Poster presentation at ACOG 56th annual meeting, New Orleans, May 3–7 2008

Lewis RW, Fugl-Meyer KS, Corona G et al (2010) Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 7:1598–1607PubMed

Lloyd EA (2005) The case of the female orgasm: bias in the science of evolution. Harvard University Press, Cambridge, MA

Long CY, Liu CM, Hsu SC et al (2006) A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 13:737–743PubMed

Mah K, Binik YM (2001) The nature of human orgasm: a critical review of major trends. Clin Psychol Rev 21:823–856PubMed

Maserejian NN, Shifren JL, Parish SJ et al (2010) The presentation of hypoactive sexual desire disorder in premenopausal women. J Sex Med 7:3439–3448PubMed

Maserejian NN, Shifren J, Parish SJ et al (2012) Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women. J Sex Marital Ther 38:41–62PubMed

Masters WH, Johnson VE (1966) Human sexual response. Little; Brown, Boston

Melnik T, Hawton K, McGuire H (2012) Interventions for vaginismus. Cochrane Database Syst Rev 12:CD001760. doi:10.​1002/​14651858.​CD001760.​pub2

Meston CM, Hull E, Levin RJ et al (2004) Disorders of orgasm in women. J Sex Med 1:66–68PubMed

Middleton LS, Kuffel SW, Heiman JR (2008) Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: a comparison between women with sexual arousal disorder and sexually healthy women. Arch Sex Behav 37:950–961PubMed

Mok K, Juraskova I, Friedlander M (2008) The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions. Breast 17:436–440PubMed

Mongomery JC, Studd JW (1991) Physiological and sexual aspects of the menopause. Brit J Hosp Med 45:300–302

Jun 30, 2017 | Posted by in UROLOGY | Comments Off on Female Sexual Dysfunction (FSD)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access